It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
A specific grid for analyzing and grading adverse events in diagnostic radiology is lacking. In France, the standard HAS grid, a generic 5-point scale adapted from the Common Terminology Criteria for Adverse Events (CTCAEs), is criticized for limited applicability in radiology. Our aim was to develop and evaluate a radiology-specific AE grid (AE-RADS) tailored to diagnostic and teleradiological practices and to compare its performance against the CTCAEs-based HAS grid regarding inter-observer reproducibility and agreement with expert consensus.
Methods
AE-RADS, structured as a decision tree with 90 items, was developed by four senior radiologists with extensive AE experience. To assess it, 100 AE cases from early 2022 were reviewed by two radiologists and two non-physician support members, all blinded to the initial AE grading. Observers rated AEs using both the HAS and AE-RADS grids, comparing severity, AE frequency per patient, sources, and types for inter-observer reproducibility and expert agreement. Tests included intra-class correlation coefficient (ICC), Fleiss Kappa and Krippendorff alpha for reproducibility and McNemar test for comparing agreement with consensus.
Results
Among 100 patients (49 women, median age 66.9 years), 104 AEs were identified. AE-RADS achieved higher inter-observer reproducibility for AE frequency (ICC = 0.690 vs. 0.642 with HAS) and for grading the most serious AE (Krippendorff alpha = 0.519 vs. 0.506 with HAS). Agreement with expert consensus was significantly greater with AE-RADS (63–81%) than with HAS (25–47%; P-value range: 0.0001–0.0051).
Conclusion
AE-RADS shows improved, though still imperfect, agreement between evaluators and experts, supporting its potential for more precise AE assessment in diagnostic imaging.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer